Serial measurements of NT-proBNP until a 30% reduction is reached during treatment of acute decompensated heart failure patients

被引：0
|
作者：
Stienen, S. [1 ]
Twerenbold, R. [2 ]
Mueller, C. E. [2 ]
Carubelli, V. [3 ]
Bayes-Genis, A. [4 ]
Magrini, L. [5 ]
Di Somma, S. [5 ]
Knebel, F. [6 ]
Pinto, Y. M. [1 ]
Kok, W. E. [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Basel Hosp, CH-4031 Basel, Switzerland
[3] Civil Hosp Brescia, Brescia, Italy
[4] Hosp Badalona Germans Trias & Pujol, Badalona, Barcelona, Spain
[5] Univ Roma La Sapienza, I-00185 Rome, Italy
[6] CCM, Berlin, Germany
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [31] Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization
    Bettencourt, Paulo
    Azevedo, Ana
    Fonseca, Luisa
    Araujo, Jose P.
    Ferreira, Susana
    Almeida, Rui
    Rocha-Goncalves, Francisco
    Ferreira, Antonio
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 117 (01) : 75 - 79
  • [32] NT-proBNP predicts outcome in heart failure patients with optimised treatment
    Iglesias, V.
    Almeida, R.
    Frioes, F.
    Pimenta, J.
    Ferreira, S.
    Azevedo, A.
    Ferreira, A.
    Bettencourt, P.
    EUROPEAN HEART JOURNAL, 2005, 26 : 182 - 182
  • [33] Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure
    Bayes-Genis, Antoni
    Pascual-Figal, Domingo
    Fabregat, Jordi
    Domingo, Maite
    Planas, Francesc
    Casas, Teresa
    Ordonez-Llanos, Jordi
    Valdes, Mariano
    Cinca, Juan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 120 (03) : 338 - 343
  • [34] The efficacy of simendan in the treatment of acute heart failure and its impact on NT-proBNP
    Li, J.
    Wang, X-Y
    Yang, Z-Y
    Li, Y.
    Yang, F.
    Yuan, P.
    Yang, J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (09) : 4027 - 4032
  • [35] Hemodynamic improvement of acutely decompensated heart failure patients is associated with decreasing levels of NT-proBNP
    Knebel, Fabian
    Schimke, Ingolf
    Ramirez, Ivan Diaz
    Schattke, Sebastian
    Eddicks, Stephan
    Borges, Adrian C.
    Baumann, Gert
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 134 (02) : 260 - 263
  • [36] Implementation of NT-ProBNP testing reduces hospital length of stay, morbidity and mortality in patients with acute decompensated heart failure
    Green, Sandy M.
    Redmond, Patrick
    Januzzi, James L.
    Aleryani, Samir
    Lee-Lewandrowski, Elizabeth
    Sluss, Patrick
    Lewandrowski, Kent B.
    CIRCULATION, 2006, 113 (21) : E806 - E807
  • [37] Use of galectin-3 and NT-proBNP as biomarkers of decompensated heart failure
    Dubolazova, YYulia
    Drapkina, O. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 172 - 172
  • [38] Relation between NT-proBNP plasma level changes and dosage of diuretic therapy in patients with acute or decompensated heart failure
    Gabrielli, F. A.
    Natali, R.
    De Marco, E.
    Savino, M.
    Lotrionte, M.
    Garramone, B.
    Comerci, G.
    Loperfido, F.
    EUROPEAN HEART JOURNAL, 2009, 30 : 874 - 874
  • [39] Stability of NT-ProBNP in patients with systolic heart failure
    Jimenez-Navarro, Manuel F.
    Fernandez-Moyano, Maria A.
    Dominguez-Franco, Antonio
    Gomez-Doblas, Juan J.
    Molero, Encarnacion
    Gomez-Hernandez, Gemma
    Morell, Miguel
    de Teresa-Galvan, Eduardo
    REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (10): : 1075 - 1078
  • [40] Relation of Kidney Function Decline and NT-proBNP With Risk of Mortality and Readmission in Acute Decompensated Heart Failure
    McCallum, Wendy
    Tighiouart, Hocine
    Kiernan, Michael S.
    Huggins, Gordon S.
    Sarnak, Mark J.
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (01): : 115 - +
12345